Related Experiment Video
Updated: Feb 10, 2026
Whole-body PET/MRI of Pediatric Patients: The Details That Matter
Published on: December 19, 2017
Special considerations for the use of pathogen reduced blood components in pediatric patients: An overview
Raymond P Goodrich1, Jerard Segatchian2
1Infectious Disease Research Center, Colorado State University, Fort Collins, CO, USA.
Insights
Pathogen-reduced blood products offer improved safety for pediatric patients needing transfusions. Their use requires careful consideration of benefits, risks, and specific pediatric needs.
Area of Science:
- Hematology
- Pediatric Transfusion Medicine
- Blood Component Therapy
Background:
- Pediatric patients have unique physiological needs requiring specialized transfusion care.
- Long-term consequences of transfusion adverse events are a significant concern in pediatric populations.
- Advances in blood component safety are crucial for improving pediatric transfusion outcomes.
Purpose of the Study:
- To review current practices for using pathogen-reduced products in pediatric patients.
- To discuss the benefits and risks of implementing these advanced blood components.
- To highlight considerations for cost-benefit and risk-benefit analyses in pediatric transfusion.
Main Methods:
- Literature review of pathogen reduction technologies in transfusion medicine.
- Analysis of pediatric-specific physiological factors influencing transfusion requirements.
- Evaluation of toxicological and immunological data for pathogen-reduced products.
Main Results:
- Pathogen reduction methods alter blood product quality and function.
- Pediatric patients may have heightened sensitivity to toxicological and immunological aspects.
- Implementation requires careful risk-benefit and cost-benefit assessment.
Conclusions:
- Pathogen-reduced products present unique challenges and considerations for pediatric transfusion.
- Further research is needed to fully understand the long-term effects in children.
- Personalized transfusion strategies are essential for optimizing pediatric patient care.
Abstract:
Pediatric patients requiring transfusion constitute one of the most challenging areas of transfusion practice. Due to the limitations posed by their particular physiological conditions they routinely require specialized component support and more personalised transfusion care than what is routinely utilized in the care of adult patients. Pediatric patients, unlike many adult patients requiring transfusion support, also generally have significant lifespans post-transfusion. This combined with the possibility of long term consequences to adverse events related to transfusion such as infection or change in immunological status drives the need to continue to use improved blood components in the transfusion support of pediatric patients. While considerable progress has been made on methods to improve the safety and efficacy of blood components, the use of these products in pediatric patients continues to be a subject of debate and additional considerations. These additional considerations arise due to the changes in blood product quality and function that is observed following treatment with pathogen reduction methods. Additional considerations regarding toxicological and immunological aspects related to these products are heightened in the case of pediatric patients. This manuscript provides an overview of current practice regarding the use of pathogen reduced products in pediatric patients with discussion of issues for consideration in their implementation in routine, including cost/benefit and risk/benefit aspects associated with their use.
Related Concept Videos
01:28Special considerations while measuring blood pressure
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
01:13Special considerations while measuring pulse
01:19Special considerations while measuring oxygen saturation
Ensuring accuracy in vital sign recordings while prioritizing patient comfort and minimizing anxiety is...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution